Abstract
Studies of the toxicity of a potential new drug form the basis of its preclinical safety evaluation and it is important that these toxicity studies are designed and conducted in a rational manner to permit the reliable interpretation and extrapolation of the resulting data to man. It is proposed that these objectives are more likely to be met with the support of pharmacokinetic data.
Generally, toxicity studies include four groups of animals, a control group and three treated groups receiving low, intermediate and high dose levels respectively. In order to assist in the proper selection of appropriate dose levels and to increase the usefulness of the data obtained from toxicity studies, information on the following should be known.
-
1.
Relationship between dose level and the extent of absorption of the test compound.
-
2.
Effect of repeated (chronic) doses on the pharmacokinetics of the test compound.
-
3.
Relationship between the age of the animal and pharmacokinetics of the test compound.
-
4.
Relationship between the dose regimen used clinically and those used in toxicity studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Down WH, Hawkins DR, Chasseaud LF (1982) Effect of the triazolobenzodiazepine estazolam on hepatic drug-metabolising enzyme activity in rats. J Pharm Pharmacol 34: 432–437.
Kaplan SA (1972) Biopharmaceutical considerations in drug formulation design and evaluation. Drug Metab Rev 1: 15–34.
Kaplan SA, Jack ML (1980) Pharmacokinetics as a tool in drug development. Progress in Drug Metabolism (J. W. Bridges and L. F. Chasseaud, eds.), vol. 4, pp. 1–55, Wiley, Chichester.
Mitchell JR, Jollow DJ (1975) Metabolic activation of drugs to toxic substances. Gastroenterology 68: 392–410.
Smyth RD, Hottendorf GH (1980) Application of pharmacokinetics and biopharmaceutics in the design of toxicological studies. Toxicol Appl Pharmacol 53: 179–195.
Watanabe PG, Ramsey JC, Gehring PJ (1980) Pharmacokinetics and metabolism of industrial chemicals. Progress in Drug Metabolism (J. W. Bridges and L. F. Chasseaud, eds.) vol. 5, pp. 311–343, Wiley, Chichester.
Yacobi A, Kamath BL, Lai C-M (1982) Pharmacokinetics in chronic animal toxicity studies. Drug Metab Rev 13: 1021–1051.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hawkins, D.R., Chasseaud, L.F. (1985). Reasons for Monitoring Kinetics in Safety Evaluation Studies. In: Chambers, P.L., Cholnoky, E., Chambers, C.M. (eds) Receptors and Other Targets for Toxic Substances. Archives of Toxicology, vol 8. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69928-3_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-69928-3_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13670-5
Online ISBN: 978-3-642-69928-3
eBook Packages: Springer Book Archive